WuXi Biologics keeps MSCI AAA ESG rating for fourth straight year

The company said it also remained in the MSCI 2026 Selection Indexes under MSCI’s updated ESG Model 5.0, which it described as the framework’s biggest overhaul since launch.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.